Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Ver. Summary Created by Modification Content Size Created at Operation
1 + 366 word(s) 366 2020-12-15 07:19:39

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Yin, N. Chylomicron retention disease. Encyclopedia. Available online: (accessed on 11 December 2023).
Yin N. Chylomicron retention disease. Encyclopedia. Available at: Accessed December 11, 2023.
Yin, Nicole. "Chylomicron retention disease" Encyclopedia, (accessed December 11, 2023).
Yin, N.(2020, December 24). Chylomicron retention disease. In Encyclopedia.
Yin, Nicole. "Chylomicron retention disease." Encyclopedia. Web. 24 December, 2020.
Chylomicron retention disease

Chylomicron retention disease is an inherited disorder that impairs the normal absorption of fats, cholesterol, and certain vitamins from food.

genetic conditions

1. Introduction

The features of chylomicron retention disease primarily affect the gastrointestinal system and nervous system.

Chylomicron retention disease begins in infancy or early childhood. Affected children have slow growth and weight gain, frequent (chronic) diarrhea, and foul-smelling stools (steatorrhea). They also have reduced blood cholesterol levels (hypocholesterolemia). Some individuals with chylomicron retention disease develop an abnormal buildup of fats in the liver called hepatic stenosis and can have an enlarged liver.

Other features of chylomicron retention disease develop later in childhood and often impair the function of the nervous system. Affected people may develop decreased reflexes (hyporeflexia) and a decreased ability to sense vibrations. Rarely, affected individuals have heart abnormalities or muscle wasting (amyotrophy).

2. Frequency

Chylomicron retention disease is a rare condition with approximately 50 cases described worldwide.

3. Causes

Mutations in a gene called SAR1B cause chylomicron retention disease. The SAR1B gene provides instructions for making a protein that is needed for the transport of molecules called chylomicrons. During digestion, chylomicrons are formed within cells called enterocytes that line the small intestine and absorb nutrients. Chylomicrons are needed to absorb fat-soluble vitamins and carry fats and cholesterol from the small intestine into the bloodstream.

SAR1B gene mutations cause the retention of chylomicrons within enterocytes and prevent their release into the bloodstream. Impaired chylomicron transport causes severely decreased absorption (malabsorption) of dietary fats and fat-soluble vitamins, leading to nutritional and developmental problems in people with chylomicron retention disease. Affected individuals are unable to absorb sufficient fats, cholesterol, and vitamins that are necessary for normal growth and development.

4. Inheritance

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

5. Other Names for This Condition

  • Anderson disease
  • Anderson syndrome
  • CMRD
  • hypobetalipoproteinemia with accumulation of apolipoprotein B-like protein in intestinal cells
  • lipid transport defect of intestine


  1. Charcosset M, Sassolas A, Peretti N, Roy CC, Deslandres C, Sinnett D, Levy E, Lachaux A. Anderson or chylomicron retention disease: molecular impact of fivemutations in the SAR1B gene on the structure and the functionality of Sar1bprotein. Mol Genet Metab. 2008 Jan;93(1):74-84.
  2. Hesse D, Jaschke A, Chung B, Schürmann A. Trans-Golgi proteins participate in the control of lipid droplet and chylomicron formation. Biosci Rep. 2013 Feb22;33(1):1-9. doi: 10.1042/BSR20120082. Review.
  3. Levy E. Insights from human congenital disorders of intestinal lipidmetabolism. J Lipid Res. 2015 May;56(5):945-62. doi: 10.1194/jlr.R052415.
  4. Sané AT, Seidman E, Peretti N, Kleme ML, Delvin E, Deslandres C, Garofalo C,Spahis S, Levy E. Understanding Chylomicron Retention Disease Through Sar1bGtpase Gene Disruption: Insight From Cell Culture. Arterioscler Thromb Vasc Biol.2017 Dec;37(12):2243-2251. doi: 10.1161/ATVBAHA.117.310121.
  5. Silvain M, Bligny D, Aparicio T, Laforêt P, Grodet A, Peretti N, Ménard D,Djouadi F, Jardel C, Bégué JM, Walker F, Schmitz J, Lachaux A, Aggerbeck LP,Samson-Bouma ME. Anderson's disease (chylomicron retention disease): a newmutation in the SARA2 gene associated with muscular and cardiac abnormalities.Clin Genet. 2008 Dec;74(6):546-52. doi: 10.1111/j.1399-0004.2008.01069.x.
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 226
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 24 Dec 2020